KRYS
Price
$138.88
Change
-$3.70 (-2.60%)
Updated
Jun 27 closing price
Capitalization
4.01B
42 days until earnings call
VKTX
Price
$26.52
Change
-$1.65 (-5.86%)
Updated
Jun 27 closing price
Capitalization
2.98B
24 days until earnings call
Interact to see
Advertisement

KRYS vs VKTX

Header iconKRYS vs VKTX Comparison
Open Charts KRYS vs VKTXBanner chart's image
Krystal Biotech
Price$138.88
Change-$3.70 (-2.60%)
Volume$418.51K
Capitalization4.01B
Viking Therapeutics
Price$26.52
Change-$1.65 (-5.86%)
Volume$6.32M
Capitalization2.98B
KRYS vs VKTX Comparison Chart in %
Loading...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KRYS vs. VKTX commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KRYS is a Buy and VKTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (KRYS: $138.88 vs. VKTX: $26.52)
Brand notoriety: KRYS and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KRYS: 112% vs. VKTX: 177%
Market capitalization -- KRYS: $4.01B vs. VKTX: $2.98B
KRYS [@Biotechnology] is valued at $4.01B. VKTX’s [@Biotechnology] market capitalization is $2.98B. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KRYS’s FA Score shows that 0 FA rating(s) are green whileVKTX’s FA Score has 0 green FA rating(s).

  • KRYS’s FA Score: 0 green, 5 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, KRYS is a better buy in the long-term than VKTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KRYS’s TA Score shows that 4 TA indicator(s) are bullish while VKTX’s TA Score has 2 bullish TA indicator(s).

  • KRYS’s TA Score: 4 bullish, 5 bearish.
  • VKTX’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, KRYS is a better buy in the short-term than VKTX.

Price Growth

KRYS (@Biotechnology) experienced а +4.85% price change this week, while VKTX (@Biotechnology) price change was +1.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

KRYS is expected to report earnings on Aug 11, 2025.

VKTX is expected to report earnings on Jul 23, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KRYS($4.01B) has a higher market cap than VKTX($2.98B). KRYS YTD gains are higher at: -11.349 vs. VKTX (-34.095). KRYS has higher annual earnings (EBITDA): 140M vs. VKTX (-171.93M). VKTX has more cash in the bank: 852M vs. KRYS (617M). VKTX has less debt than KRYS: VKTX (1M) vs KRYS (9.66M). KRYS has higher revenues than VKTX: KRYS (333M) vs VKTX (0).
KRYSVKTXKRYS / VKTX
Capitalization4.01B2.98B135%
EBITDA140M-171.93M-81%
Gain YTD-11.349-34.09533%
P/E Ratio33.30N/A-
Revenue333M0-
Total Cash617M852M72%
Total Debt9.66M1M966%
FUNDAMENTALS RATINGS
KRYS vs VKTX: Fundamental Ratings
KRYS
VKTX
OUTLOOK RATING
1..100
3964
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
40
Fair valued
PROFIT vs RISK RATING
1..100
4177
SMR RATING
1..100
5791
PRICE GROWTH RATING
1..100
6264
P/E GROWTH RATING
1..100
98100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VKTX's Valuation (40) in the Biotechnology industry is in the same range as KRYS (71) in the Pharmaceuticals Major industry. This means that VKTX’s stock grew similarly to KRYS’s over the last 12 months.

KRYS's Profit vs Risk Rating (41) in the Pharmaceuticals Major industry is somewhat better than the same rating for VKTX (77) in the Biotechnology industry. This means that KRYS’s stock grew somewhat faster than VKTX’s over the last 12 months.

KRYS's SMR Rating (57) in the Pharmaceuticals Major industry is somewhat better than the same rating for VKTX (91) in the Biotechnology industry. This means that KRYS’s stock grew somewhat faster than VKTX’s over the last 12 months.

KRYS's Price Growth Rating (62) in the Pharmaceuticals Major industry is in the same range as VKTX (64) in the Biotechnology industry. This means that KRYS’s stock grew similarly to VKTX’s over the last 12 months.

KRYS's P/E Growth Rating (98) in the Pharmaceuticals Major industry is in the same range as VKTX (100) in the Biotechnology industry. This means that KRYS’s stock grew similarly to VKTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KRYSVKTX
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
81%
MACD
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 10 days ago
77%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 13 days ago
76%
Bearish Trend 10 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
83%
Aroon
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MXECX11.150.09
+0.81%
Empower Core Strategies Intl Eq Instl
JIGFX52.360.27
+0.52%
Janus Henderson Overseas I
VGSCX33.760.15
+0.45%
Virtus Duff & Phelps Glb Rl Estt Secs C
BQMGX24.700.07
+0.28%
Bright Rock Mid Cap Growth Instl
FNWFX88.860.20
+0.23%
American Funds New World F3

KRYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRYS has been loosely correlated with XNCR. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if KRYS jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRYS
1D Price
Change %
KRYS100%
-2.60%
XNCR - KRYS
54%
Loosely correlated
-3.10%
IDYA - KRYS
54%
Loosely correlated
-4.13%
CRNX - KRYS
54%
Loosely correlated
-0.10%
ACLX - KRYS
54%
Loosely correlated
+0.90%
CGON - KRYS
54%
Loosely correlated
-0.46%
More

VKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VKTX has been loosely correlated with GPCR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if VKTX jumps, then GPCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VKTX
1D Price
Change %
VKTX100%
-5.86%
GPCR - VKTX
49%
Loosely correlated
N/A
CRNX - VKTX
49%
Loosely correlated
-0.10%
KRYS - VKTX
47%
Loosely correlated
-2.60%
ALT - VKTX
47%
Loosely correlated
-54.60%
ROIV - VKTX
46%
Loosely correlated
-1.81%
More